Function Oncology, Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Function Oncology, Inc - overview
Established
2023
Location
San Diego, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2023, Function Oncology, Inc. provides a platform to measure gene function and identifies valuable therapeutic opportunities. As of 2023, the company is headed by its CEO Srinath Sampath. In April 2023, the firm raised USD 28 million in Series A funding co-led by investors Andreessen Horowitz and Section 32, with participation from other investors Alexandria Venture Investments and Casdin Capital.
The company offers a platform for primary cell CRISPR profiling as well as personalized medicine based on functional genomics. Additionally, the firm identifies valuable therapeutic opportunities for patients and also develops the next generation of cancer therapies. The company plan to use the April 2023 funding to identify optimal therapeutic opportunities for cancer patients and develop new targeted treatments.
Current Investors
Alexandria Venture Investments, Andreessen Horowitz, Casdin Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biotechnology
Website
www.functiononcology.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.